IRDOpus Genetics Inc.
$3.91
$0.02
(0.51%)
Closed $3.91
$0.00
(0.00%)
After Hours
Reported EarningsMay 12
Mkt Cap$316.63M
Vol553,682.00
Fundamentals
Mkt Cap
$316.63M
Volume
-
52W High
$5.81
52W Low
$0.9011
PE Ratio
-2.89
Avg. Volume
908,661.48
EPS (Annual)
-$0.797
Rev/Employee
$507,000.00
Earnings
May 12
41
Bearish Sentiment
How do you feel about IRD?
Opus Genetics, Inc. (IRD) Reports Q1 Loss, Misses Revenue Estimates
Opus Genetics, Inc. (IRD) delivered earnings and revenue surprises of -374.68% and -23.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Certara, Inc. (CERT) Q1 Earnings Miss Estimates
Certara (CERT) delivered earnings and revenue surprises of -20.57% and +1.22%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Opus Genetics, Inc. (NASDAQ:IRD) Receives Average Recommendation of "Moderate Buy" from Analysts
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the thirteen analysts that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating...
MarketBeat
Opus Genetics (NASDAQ:IRD) Now Covered by Analysts at Citizens Jmp
Citizens Jmp initiated coverage on Opus Genetics in a report on Tuesday. They issued a "market perform" rating and a $12.00 price target for the company...
MarketBeat
Insider Selling: Opus Genetics (NASDAQ:IRD) President Sells 7,470 Shares of Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) President Benjamin Yerxa sold 7,470 shares of the firm's stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $5.24, for a total transaction of $39,142.80. Following the sale, the president owned 711,535...
MarketBeat
Opus Genetics (NASDAQ:IRD) CFO Robert Gagnon Sells 7,842 Shares
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) CFO Robert Gagnon sold 7,842 shares of the company's stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of...
MarketBeat
Opus Genetics (NASDAQ:IRD) Insider Ashwath Jayagopal Sells 7,542 Shares
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) insider Ashwath Jayagopal sold 7,542 shares of the firm's stock in a transaction dated Thursday, April 23rd. The shares were sold at an average...
MarketBeat
Opus Genetics (NASDAQ:IRD) President Benjamin Yerxa Sells 7,470 Shares
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) President Benjamin Yerxa sold 7,470 shares of Opus Genetics stock in a transaction dated Thursday, April 23rd. The shares were sold at an average...
MarketBeat
Opus Genetics (NASDAQ:IRD) COO Sells $24,518.34 in Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) COO Joseph Schachle sold 4,697 shares of the stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of...
MarketBeat
Opus Genetics (NASDAQ:IRD) CEO Sells $49,647.42 in Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) CEO George Magrath sold 9,511 shares of the firm's stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $5.22...
MarketBeat
<
1
2
...
>